Lisa D Levine1, Jennifer Lewey2, Nathanael Koelper3, Katheryne L Downes4, Zolt Arany5, Michal A Elovitz6, Mary D Sammel7, Bonnie Ky8. 1. Maternal and Child Health Research Center, Department of Obstetrics & Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Electronic address: lisa.levine@uphs.upenn.edu. 2. Division of Cardiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 3. Center for Research on Reproduction and Women's Health, Department of Obstetrics & Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 4. Foundation for Orthopedic Research and Education, Tampa, FL, USA. 5. Division of Cardiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Cardiovascular Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 6. Maternal and Child Health Research Center, Department of Obstetrics & Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 7. Department of Biostatistics, Epidemiology and Informatics, Center for Clinical Epidemiology and Biostatistics, and Women's Health Clinical Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 8. Division of Cardiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Cardiovascular Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Biostatistics, Epidemiology and Informatics, Center for Clinical Epidemiology and Biostatistics, and Women's Health Clinical Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Abstract
BACKGROUND: Cardiovascular disease (CVD) and preeclampsia both disproportionally affect African American women. Evidence continues to grow linking a history of preeclampsia to future CVD. Therefore, we sought to determine whether abnormalities in cardiac function, as determined by echocardiography, could be identified at the time of preeclampsia diagnosis in African American women, and if they persist into the early postpartum period. STUDY DESIGN: This prospective blinded longitudinal cohort study was performed from April 2015 to May 2017. We identified African American women diagnosed with preterm (<37 weeks) preeclampsia with severe features and compared them to control normotensive pregnant women matched on race, gestational age, maternal age, and body mass index. We obtained transthoracic echocardiograms on cases and controls at time of diagnosis and again 4-12 weeks postpartum. We quantified the systolic function with longitudinal strain, ventricular-arterial coupling parameters and diastolic function. RESULTS: There were 29 matched (case-control) pairs of African American women for a total of 58 women. At time of preeclampsia diagnosis, there was more abnormal cardiac function as evidenced by worse cardiac systolic function (longitudinal strain), increased chamber stiffness (end systolic elastance), and worse diastolic function (E/e') in preeclampsia cases compared to controls. These findings persisted 4-12 weeks postpartum. There were additional notable abnormalities in E/A, and Ea (arterial load) postpartum, indicative of potentially worse diastolic function and increased arterial stiffness in the postpartum period. CONCLUSIONS: Among African American women, we found notable cardiac function differences between women with severe preeclampsia and healthy pregnant controls that persist postpartum.
BACKGROUND:Cardiovascular disease (CVD) and preeclampsia both disproportionally affect African American women. Evidence continues to grow linking a history of preeclampsia to future CVD. Therefore, we sought to determine whether abnormalities in cardiac function, as determined by echocardiography, could be identified at the time of preeclampsia diagnosis in African American women, and if they persist into the early postpartum period. STUDY DESIGN: This prospective blinded longitudinal cohort study was performed from April 2015 to May 2017. We identified African American women diagnosed with preterm (<37 weeks) preeclampsia with severe features and compared them to control normotensive pregnant women matched on race, gestational age, maternal age, and body mass index. We obtained transthoracic echocardiograms on cases and controls at time of diagnosis and again 4-12 weeks postpartum. We quantified the systolic function with longitudinal strain, ventricular-arterial coupling parameters and diastolic function. RESULTS: There were 29 matched (case-control) pairs of African American women for a total of 58 women. At time of preeclampsia diagnosis, there was more abnormal cardiac function as evidenced by worse cardiac systolic function (longitudinal strain), increased chamber stiffness (end systolic elastance), and worse diastolic function (E/e') in preeclampsia cases compared to controls. These findings persisted 4-12 weeks postpartum. There were additional notable abnormalities in E/A, and Ea (arterial load) postpartum, indicative of potentially worse diastolic function and increased arterial stiffness in the postpartum period. CONCLUSIONS: Among African American women, we found notable cardiac function differences between women with severe preeclampsia and healthy pregnant controls that persist postpartum.
Authors: Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy Journal: Circulation Date: 2009-03-26 Impact factor: 29.690
Authors: Arthur Jason Vaught; Lara C Kovell; Linda M Szymanski; Susan A Mayer; Sara M Seifert; Dhananjay Vaidya; Jamie D Murphy; Cynthia Argani; Anna O'Kelly; Sarah York; Pamela Ouyang; Monica Mukherjee; Sammy Zakaria Journal: J Am Coll Cardiol Date: 2018-07-03 Impact factor: 24.094
Authors: Hari K Narayan; Brian Finkelman; Benjamin French; Theodore Plappert; David Hyman; Amanda M Smith; Kenneth B Margulies; Bonnie Ky Journal: Circulation Date: 2017-01-19 Impact factor: 29.690
Authors: Sajid Shahul; Diego Medvedofsky; Julia B Wenger; Junaid Nizamuddin; Samuel M Brown; Surichhya Bajracharya; Saira Salahuddin; Ravi Thadhani; Ariel Mueller; Avery Tung; Roberto M Lang; Zoltan Arany; Daniel Talmor; S Ananth Karumanchi; Sarosh Rana Journal: Hypertension Date: 2016-04-25 Impact factor: 10.190
Authors: Paaladinesh Thavendiranathan; Frédéric Poulin; Ki-Dong Lim; Juan Carlos Plana; Anna Woo; Thomas H Marwick Journal: J Am Coll Cardiol Date: 2014-04-02 Impact factor: 24.094
Authors: Ian S Patten; Sarosh Rana; Sajid Shahul; Glenn C Rowe; Cholsoon Jang; Laura Liu; Michele R Hacker; Julie S Rhee; John Mitchell; Feroze Mahmood; Philip Hess; Caitlin Farrell; Nicole Koulisis; Eliyahu V Khankin; Suzanne D Burke; Igor Tudorache; Johann Bauersachs; Federica del Monte; Denise Hilfiker-Kleiner; S Ananth Karumanchi; Zoltan Arany Journal: Nature Date: 2012-05-09 Impact factor: 49.962
Authors: Lisa Levine; Zolt Arany; Adina Kern-Goldberger; Nathanael Koelper; Jennifer Lewey; Mary D Sammel; Michal A Elovitz; Bonnie Ky Journal: Hypertens Pregnancy Date: 2020-12-20 Impact factor: 2.108
Authors: Fergus P McCarthy; Jamie M O'Driscoll; Paul T Seed; Anna Placzek; Carolyn Gill; Jenie Sparkes; Lucilla Poston; Mike Marber; Andrew H Shennan; Basky Thilaganathan; Paul Leeson; Lucy C Chappell Journal: Hypertension Date: 2021-08-30 Impact factor: 10.190